Genprex share price today

(GNPX)

Genprex share price is $0.93 & ₹79.23 as on 25 Dec 2024, 2.30 'hrs' IST

$0.93

▲

-0.01

(-0.6%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Genprex share price in Dollar and Rupees. Guide to invest in Genprex from India. Also see the sentimental analysis on Indian investors investing in Genprex. Get details on the Indian mutual funds that are investing in Genprex. Get Analyst recommendations and forecasts along with all the Genprex's financials.

Genprex share price movements

Today's Low: $0.88
Today's High: $0.94
$0.93
5.38%
Downside
Day's Volatility :6.68%
Upside
1.38%
52 Weeks Low: $0.28
52 Weeks High: $14.40
$0.93
69.83%
Downside
52 Weeks Volatility :98.05%
Upside
93.54%

Genprex Returns

Period	Genprex Inc	Index (Russel 2000)
3 Months	165.58%	0.0%
6 Months	-52.88%	0.0%
1 Year	-89.33%	0.0%
3 Years	-98.28%	-21.1%

Genprex Key Statistics

in dollars & INR

Previous Close	$0.9338
Open	$0.9
Today's High	$0.943
Today's Low	$0.88
Market Capitalization	$7.9M
Today's Volume	$318.0K
52 Week High	$14.4
52 Week Low	$0.2806
Revenue TTM	$0.0
EBITDA	$-26.3M
Earnings Per Share (EPS)	$-10.69
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-318.88%

How to invest in Genprex from India?

It is very easy for Indian residents to invest directly in Genprex from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Genprex stock in both Indian Rupees (INR) and US Dollars (USD). Search for Genprex or GNPX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Genprex or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Genprex shares which would translate to 0.916 fractional shares of Genprex as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Genprex, in just a few clicks!

Returns in Genprex for Indian investors in Rupees

Investment Value

₹1,00,000

Genprex investment value today

Current value as on today

₹12,928

Returns

₹87,072

(-87.07%)

Returns from Genprex Stock

₹89,310 (-89.31%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Genprex

-60.68%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Investment in Genprex from India has reduced in the last 30 days as on Dec 26, 2024. -60.68% less purchase transactions for Genprex in the last 30 days versus the previous period.

-42%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Genprex on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -42% less investors are searching Genprex in the last 30 days versus the previous period.

Global Institutional Holdings in Genprex

UBS Group AG
0.66%
TWO SIGMA SECURITIES, LLC
0.27%
HighTower Advisors, LLC
0.25%
Geode Capital Management, LLC
0.19%
HRT FINANCIAL LLC
0.18%
Vanguard Group Inc
0.18%

Analyst Recommendation on Genprex

Buy

77%Buy

22%Hold

0%Sell

Based on 9 Wall street analysts offering stock ratings for Genprex(by analysts ranked 0 to 5 stars)

Based on 9 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Genprex

What analysts predicted

Upside of 706.45%

Current:

$0.93

Target:

$7.50

Insights on Genprex

Price Movement
In the last 3 months, GNPX stock has moved up by 165.6%
GNPX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 116.2%
GNPX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 123.6%

Genprex Technicals Summary

Sell

Neutral

Buy

Genprex is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Genprex Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Genprex Inc	-17.13%	-52.88%	-89.33%	-98.28%	-92.21%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Genprex Inc	NA	NA	NA	-4.25	-3.19	-1.46	NA	4.99
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Genprex Inc	Buy	$7.9M	-92.21%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Genprex

genprex is mapping the future of cancer care. genprex's mission is to address the unmet medical needs of a growing population of cancer patients worldwide, through the development of a novel class of cancer drugs: immunogene therapy. our revolutionary clinical-stage products work synergistically with other approved and pipeline drugs to expand clinical indications for various cancers. about oncoprex® and lung cancer lung cancer is the second most common cancer in the u.s. but the leading cause of cancer death. there are approximately 225,000 new lung cancer cases in the u.s. per year and 1.8 million worldwide. the 5-year survival rate of stage iv non-small cell lung cancer (nsclc) is less than 1%, and treatment options beyond chemotherapy are lacking. approved nsclc targeted treatment options outside of chemo/radiation therapies only benefit a minority of patients. oncoprex® may now fill that gap by offering a targeted treatment option for a majority of nsclc patients. oncoprex® is cur

Organization	Genprex
Employees	21
CEO	Dr. Mark S. Berger M.D.
Industry	Health Technology

Management People of Genprex

Name	Title
Dr. Mark S. Berger M.D.	Chief Medical Officer
Mr. Ryan M. Confer M.S.	President, CEO, CFO & Director
Mr. David M. Schloss	Senior Vice President of Human Resources
Mr. Thomas C. Gallagher Esq.	Senior Vice President of Intellectual Property & Licensing
Dr. Suzanne Thornton-Jones Ph.D.	Senior Vice President of Regulatory Affairs & Quality
Dr. Jack A. Roth F.A.C.S., M.D.	Chairman of Scientific & Medical Advisory Board

Important FAQs about investing in Genprex from India :

What is Genprex share price today?

Genprex share price today stands at $0.93, Open: $0.90 ; Previous Close: $0.93 ; High: $0.94 ; Low: $0.88 ; 52 Week High: $14.40 ; 52 Week Low: $0.28. The stock opens at $0.90, after a previous close of $0.93. The stock reached a daily high of $0.94 and a low of $0.88, with a 52-week high of $14.40 and a 52-week low of $0.28.

Can Indians buy Genprex shares?

Yes, Indians can invest in the Genprex (GNPX) from India.

With INDmoney, you can buy Genprex at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Genprex at zero transaction cost.

How can I buy Genprex shares from India?

It is very easy to buy Genprex from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Genprex be purchased?

Yes, you can buy fractional shares of Genprex with INDmoney app.

What are the documents required to start investing in Genprex stocks?

To start investing in Genprex, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.